Sarah Pringle

Sarah Pringle is a reporter focusing on auctions in the retail and technology sectors. Prior to joining The Deal, Pringle reported on U.S. and Canadian equity markets at Bloomberg News in New York and MarketWatch in San Francisco.

Recent Articles By The Author

GNC Goes South After C-Suite Shake-Up

GNC Goes South After C-Suite Shake-Up

Shares in the retailer of nutritional supplements plummet on Thursday as it announces the departure of CEO Archbold after a less than two-year-long turnaround attempt.

Cerner Could Be a Prized Asset for IBM

Cerner Could Be a Prized Asset for IBM

The health care IT firm is viewed as a 'crown jewel' but may still be too large of an asset for logical buyers to get comfortable with.

Abbott's Alere Deal Continues To Face Uncertainty

Abbott's Alere Deal Continues To Face Uncertainty

The medical device company has two pending acquisitions worth just under $40 billion combined.

Monsanto Rebuffs Bayer Again

Monsanto Rebuffs Bayer Again

The St. Louis-based target claims Bayer's revised $63.5 billion bid remains 'financially inadequate."

Analyst: Merck's Fundamentals Don't Warrant Current Valuation

Analyst: Merck's Fundamentals Don't Warrant Current Valuation

BMO Capital Markets downgrades the pharmaceutical giant ahead of Q2 earnings as pricing pressure mounts and other potential headwinds begin to emerge.